These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 30632789

  • 1. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
    Shen XM, Cheng J.
    DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
    [Abstract] [Full Text] [Related]

  • 2. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R, Sun X, Deng YS, Qiu XW.
    Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068
    [Abstract] [Full Text] [Related]

  • 3. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
    Tan DQ.
    Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
    [Abstract] [Full Text] [Related]

  • 4. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.
    Seven M, Batar B, Unal S, Yesil G, Yuksel A, Guven M.
    Mol Biol Rep; 2014 Jan; 41(1):331-6. PubMed ID: 24213830
    [Abstract] [Full Text] [Related]

  • 5. ABCB1 1199G>A Polymorphism Affects the Intracellular Accumulation of Antidepressants in LLC-PK1 Recombinant Cell Lines.
    Gao YL, He B.
    DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
    [Abstract] [Full Text] [Related]

  • 6. ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide.
    Jiang B, Yan LJ, Wu Q.
    DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
    [Abstract] [Full Text] [Related]

  • 7. A multi-system approach assessing the interaction of anticonvulsants with P-gp.
    Dickens D, Yusof SR, Abbott NJ, Weksler B, Romero IA, Couraud PO, Alfirevic A, Pirmohamed M, Owen A.
    PLoS One; 2013 May; 8(5):e64854. PubMed ID: 23741405
    [Abstract] [Full Text] [Related]

  • 8. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
    Woodahl EL, Crouthamel MH, Bui T, Shen DD, Ho RJ.
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):183-8. PubMed ID: 19123050
    [Abstract] [Full Text] [Related]

  • 9. Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: An in vitro evaluation with focus on antiepileptic drugs.
    Ferreira A, Rodrigues M, Fortuna A, Falcão A, Alves G.
    Food Res Int; 2018 Jan; 103():110-120. PubMed ID: 29389596
    [Abstract] [Full Text] [Related]

  • 10. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.
    Jamroziak K, Balcerczak E, Smolewski P, Robey RW, Cebula B, Panczyk M, Kowalczyk M, Szmigielska-Kapłon A, Mirowski M, Bates SE, Robak T.
    Pharmacol Rep; 2006 Jan; 58(5):720-8. PubMed ID: 17085864
    [Abstract] [Full Text] [Related]

  • 11. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
    Kuteykin-Teplyakov K, Luna-Tortós C, Ambroziak K, Löscher W.
    Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635
    [Abstract] [Full Text] [Related]

  • 12. MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.
    Fung KL, Pan J, Ohnuma S, Lund PE, Pixley JN, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM.
    Cancer Res; 2014 Jan 15; 74(2):598-608. PubMed ID: 24305879
    [Abstract] [Full Text] [Related]

  • 13. The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein.
    Miyamoto R, Nozawa T, Shiozuka K, Tabata K.
    J Pharm Sci; 2019 Mar 15; 108(3):1085-1089. PubMed ID: 30339864
    [Abstract] [Full Text] [Related]

  • 14. Is aspirin a substrate of MDR1/P-glycoprotein?
    Singh R, Naik T, Nigam A, Chatterjee S, Rajanna P, Shen H, Iyer R.
    Xenobiotica; 2020 Oct 15; 50(10):1258-1264. PubMed ID: 32302241
    [Abstract] [Full Text] [Related]

  • 15. Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs.
    Peng R, Zhang H, Zhang Y, Wei DY.
    Xenobiotica; 2016 Oct 15; 46(10):948-52. PubMed ID: 26822676
    [Abstract] [Full Text] [Related]

  • 16. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
    Zhu HJ, Wang JS, Donovan JL, Jiang Y, Gibson BB, DeVane CL, Markowitz JS.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):148-58. PubMed ID: 17963743
    [Abstract] [Full Text] [Related]

  • 17. [The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy].
    Białecka M, Hnatyszyn G, Bielicka-Cymerman J, Droździk M.
    Neurol Neurochir Pol; 2005 Jan 14; 39(6):476-81. PubMed ID: 16355305
    [Abstract] [Full Text] [Related]

  • 18. Association between C3435T polymorphism of MDR1 gene and the incidence of drug-resistant epilepsy in the population of Polish children.
    Stasiołek M, Romanowicz H, Połatyńska K, Chamielec M, Skalski D, Makowska M, Smolarz B.
    Behav Brain Funct; 2016 Jul 08; 12(1):21. PubMed ID: 27391700
    [Abstract] [Full Text] [Related]

  • 19. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.
    Giessmann T, May K, Modess C, Wegner D, Hecker U, Zschiesche M, Dazert P, Grube M, Schroeder E, Warzok R, Cascorbi I, Kroemer HK, Siegmund W.
    Clin Pharmacol Ther; 2004 Sep 08; 76(3):192-200. PubMed ID: 15371980
    [Abstract] [Full Text] [Related]

  • 20. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep 08; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.